Abstract
BackgroundB-cell depletion therapy (BCDT) may improve the efficacy of conventional idiopathic inflammatory myopathies (IIM) treatment. However, administration of such drugs is associated with increased risk of adverse events, first of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
